Nutriband Inc (NTRB) Stock Price, Quote & News - Mboum

Company Profile

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company h...

Industry: Biotechnology

Sector: Healthcare

Phone: 407 377 6695

Website: www.nutriband.com

Address:

121 South Orange Avenue, Suite 1500, Orlando, United States

NVDAMillionaire Oct. 3 at 8:11 PM

$NTRB Brilliant piece that captures NTRB's situation perfectly. So if you want to update your understanding of NTRB or get to know NTRB better, this is essential reading. https://beyondspx.com/quote/NTRB/analysis/nutriband-s-aversa-technology-a-catalyst-for-growth-in-abuse-deterrent-pharmaceuticals-nasdaq-ntrb

0 · Reply

Covode13 Oct. 3 at 1:57 PM

$CRDL $NTRB I ment

0 · Reply

TraderMadness Oct. 2 at 7:15 PM

$NTRB - watching the MACD for starting to curl upward. May be signaling move up to test recent highs incoming. $SPY $QQQ

0 · Reply

NNTrader Oct. 2 at 4:11 PM

$NTRB too bullish

0 · Reply

JoeyG527 Oct. 2 at 1:37 PM

$NTRB https://youtu.be/wAiL4rgwkD0

0 · Reply

Enzo4u Oct. 2 at 2:53 AM

$NTRB just jump to 15 :)

0 · Reply

lastpenny101 Oct. 1 at 7:44 PM

$NTRB https://youtube.com/shorts/hRFu6MFq1Gw?si=ToN2BWXBfiU1dA3r

0 · Reply

TraderMadness Oct. 1 at 3:51 PM

$NTRB transdermal delivery offers stock trade around opioid addiction crisis. https://youtube.com/shorts/hRFu6MFq1Gw?feature=share

0 · Reply

NNTrader Sep. 29 at 8:27 PM

$NTRB I heard FDA provides feedback within 30 days after meeting

0 · Reply

Frio2 Sep. 29 at 2:59 PM

$NTRB what ever came of the meeting with the FDA?

1 · Reply

Latest News on NTRB

Nutriband Inc. to Present at the MicroCap Rodeo Conference

Sep 24, 2025, 4:05 PM EDT - 10 days ago

Nutriband Inc. to Present at the MicroCap Rodeo Conference

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

Sep 10, 2025, 9:15 AM EDT - 24 days ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

Sep 3, 2025, 4:01 PM EDT - 4 weeks ago

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

Aug 18, 2025, 9:00 AM EDT - 6 weeks ago

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

Aug 11, 2025, 5:00 AM EDT - 7 weeks ago

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Aug 8, 2025, 8:00 AM EDT - 2 months ago

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

Jul 18, 2025, 9:15 AM EDT - 2 months ago

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

Jul 2, 2025, 8:05 AM EDT - 3 months ago

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

Jul 1, 2025, 7:00 AM EDT - 3 months ago

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

Jun 9, 2025, 7:30 AM EDT - 4 months ago

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

Nutriband CEO Publishes Letter to Shareholders

Apr 30, 2025, 7:30 AM EDT - 5 months ago

Nutriband CEO Publishes Letter to Shareholders

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

Apr 11, 2025, 7:00 AM EDT - 6 months ago

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

Apr 4, 2025, 5:41 PM EDT - 6 months ago

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

Nutriband Signs Partnership Agreement with Charlotte FC

Apr 4, 2025, 7:00 AM EDT - 6 months ago

Nutriband Signs Partnership Agreement with Charlotte FC

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

Feb 21, 2025, 7:00 AM EST - 8 months ago

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Feb 13, 2025, 7:00 AM EST - 8 months ago

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

Feb 7, 2025, 8:45 AM EST - 8 months ago

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

Nutriband Issues Letter to Shareholders

Dec 31, 2024, 7:00 AM EST - 9 months ago

Nutriband Issues Letter to Shareholders

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Dec 27, 2024, 9:25 AM EST - 10 months ago

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Dec 4, 2024, 9:00 AM EST - 10 months ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

Nov 27, 2024, 7:00 AM EST - 11 months ago

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

Oct 31, 2024, 8:35 AM EDT - 1 year ago

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

Oct 17, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

Oct 2, 2024, 7:00 AM EDT - 1 year ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Sep 24, 2024, 7:00 AM EDT - 1 year ago

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Sep 20, 2024, 6:50 AM EDT - 1 year ago

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

Nutriband Inc. Authorizes $1M Share Buyback Program

Sep 16, 2024, 4:00 PM EDT - 1 year ago

Nutriband Inc. Authorizes $1M Share Buyback Program

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Sep 4, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

Jul 19, 2024, 7:00 AM EDT - 1 year ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

Jul 15, 2024, 7:00 AM EDT - 1 year ago

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

Jun 20, 2024, 7:00 AM EDT - 1 year ago

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

May 16, 2024, 7:00 AM EDT - 1 year ago

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

May 10, 2024, 9:00 AM EDT - 1 year ago

Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Apr 23, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

Nutriband Inc. Announces $8.4M Private Placement

Apr 19, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Announces $8.4M Private Placement

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

Mar 25, 2024, 7:00 AM EDT - 1 year ago

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting

Mar 4, 2024, 7:00 AM EST - 1 year ago

Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting

Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st

Jan 29, 2024, 7:00 AM EST - 1 year ago

Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

Nov 28, 2023, 7:00 AM EST - 2 years ago

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape

Nov 8, 2023, 7:00 AM EST - 2 years ago

Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape

Nutriband's Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm

Oct 11, 2023, 7:42 AM EDT - 2 years ago

Nutriband's Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm

Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology

Sep 20, 2023, 7:30 AM EDT - 2 years ago

Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology

Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023

Sep 12, 2023, 7:00 AM EDT - 2 years ago

Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023

Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

Sep 11, 2023, 7:00 AM EDT - 2 years ago

Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 30, 2023, 8:00 AM EDT - 2 years ago

Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador

Jul 27, 2023, 8:30 AM EDT - 2 years ago

Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings

Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission

Jul 14, 2023, 9:20 AM EDT - 2 years ago

Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission

Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology

Jun 23, 2023, 7:00 AM EDT - 2 years ago

Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology

Nutriband to Attend 2023 BIO International Convention

May 10, 2023, 8:00 AM EDT - 2 years ago

Nutriband to Attend 2023 BIO International Convention

NVDAMillionaire Oct. 3 at 8:11 PM

$NTRB Brilliant piece that captures NTRB's situation perfectly. So if you want to update your understanding of NTRB or get to know NTRB better, this is essential reading. https://beyondspx.com/quote/NTRB/analysis/nutriband-s-aversa-technology-a-catalyst-for-growth-in-abuse-deterrent-pharmaceuticals-nasdaq-ntrb

0 · Reply

Covode13 Oct. 3 at 1:57 PM

$CRDL $NTRB I ment

0 · Reply

TraderMadness Oct. 2 at 7:15 PM

$NTRB - watching the MACD for starting to curl upward. May be signaling move up to test recent highs incoming. $SPY $QQQ

0 · Reply

NNTrader Oct. 2 at 4:11 PM

$NTRB too bullish

0 · Reply

JoeyG527 Oct. 2 at 1:37 PM

$NTRB https://youtu.be/wAiL4rgwkD0

0 · Reply

Enzo4u Oct. 2 at 2:53 AM

$NTRB just jump to 15 :)

0 · Reply

lastpenny101 Oct. 1 at 7:44 PM

$NTRB https://youtube.com/shorts/hRFu6MFq1Gw?si=ToN2BWXBfiU1dA3r

0 · Reply

TraderMadness Oct. 1 at 3:51 PM

$NTRB transdermal delivery offers stock trade around opioid addiction crisis. https://youtube.com/shorts/hRFu6MFq1Gw?feature=share

0 · Reply

NNTrader Sep. 29 at 8:27 PM

$NTRB I heard FDA provides feedback within 30 days after meeting

0 · Reply

Frio2 Sep. 29 at 2:59 PM

$NTRB what ever came of the meeting with the FDA?

1 · Reply

NNTrader Sep. 25 at 6:28 PM

$NTRB keeps above $7 which is good

0 · Reply

NetworkNewsWire Sep. 25 at 5:24 PM

InvestorNewsBreaks – $NTRB to Present at MicroCap Rodeo Conference https://ibn.fm/hzdke

0 · Reply

TraderMadness Sep. 23 at 5:12 PM

If $NTRB can assist in reducing down number of people getting addicted to Fentanyl that would be huge, and would bit radars like CNBC

0 · Reply

TraderMadness Sep. 23 at 2:01 PM

Video summary of $NTRB Fentanyl delivery system, and how it could assist in solving the addiction crisis. https://www.youtube.com/watch?v=ldnDU3eMZNg

0 · Reply

Covode13 Sep. 22 at 2:12 PM

$NTRB so what happened with the meeting and next move for approval?

1 · Reply

intratio Sep. 21 at 6:01 PM

Data insight $NTRB: Computational framework detects bearish breakdown immediate dynamics + strategic challenges strategic positioning. Momentum decay reinforcing breakdown risk. Classification: bearish.

1 · Reply

NetworkNewsWire Sep. 19 at 6:10 PM

MissionIRNewsBreaks – $NTRB Eyes Clear Development Pathway for AVERSA(TM) Technology https://ibn.fm/9ddbH

0 · Reply

electrojpatz Sep. 19 at 11:07 AM

$NTRB hopefully we get news at 9am, judging by yesterdays volume we dont have much interest by investors for this meeting

1 · Reply

BullInvest Sep. 19 at 1:34 AM

$NTRB any info on what happened on the meeting?

0 · Reply

NNTrader Sep. 18 at 7:08 PM

$NTRB nice move

0 · Reply

NNTrader Sep. 18 at 4:11 PM

$NTRB any news about FDA meeting?

0 · Reply

SYMMBOL Sep. 18 at 12:18 PM

$NTRB what time is the meeting with the FDA?

0 · Reply